Publication: Risk of gastrointestinal events among patients with sarcoidosis: A population-based study 1976-2013
Issued Date
2018-10-18
Resource Type
ISSN
2532179X
11240490
11240490
Other identifier(s)
2-s2.0-85055269538
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Sarcoidosis Vasculitis and Diffuse Lung Diseases. Vol.35, No.3 (2018)
Suggested Citation
Patompong Ungprasert, Cynthia S. Crowson, Eric L. Matteson Risk of gastrointestinal events among patients with sarcoidosis: A population-based study 1976-2013. Sarcoidosis Vasculitis and Diffuse Lung Diseases. Vol.35, No.3 (2018). Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/46247
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Risk of gastrointestinal events among patients with sarcoidosis: A population-based study 1976-2013
Other Contributor(s)
Abstract
© 1885 Mattioli. Background: An increased risk of gastrointestinal (GI) diseases has been observed in immune-mediated disease but the risk in patients with sarcoidosis is not known. Objectives: Tis study was undertaken to characterize the risk of GI diseases in patients with sarcoidosis. Methods: A population-based cohort of 345 incident cases of sarcoidosis among Olmsted County, Minnesota residents in 1976-2013 was identifed. A cohort of 345 sex and age-matched comparators were also identifed from the same underlying population. Medical records of both groups were reviewed for GI diseases. Cox models adjusted for age, sex and calendar year were used to compare the rate of development of GI diseases between the groups. In addition, Cox models were used to evaluate the association between use of immunosuppressive agents and the development of GI diseases among patients with sarcoidosis. Results: GI events occurred in 101 cases and 63 comparators, corresponding to an adjusted hazard ratio (HR) of 1.90 (95% confdence interval [CI] 1.38-2.61). Patients with sarcoidosis had an increased risk for both upper (HR 1.90; 95%CI 1.27-2.83) and lower GI events (HR 1.97; 95%CI 1.27-3.05) relative to comparators. By disease type, patients with sarcoidosis had a signifcantly elevated risk of upper GI ulcer, upper GI hemorrhage and diverticulitis. Regarding medication use, the only signifcant association was an increased risk of upper GI events among biologic agent users (HR 11.09; 95%CI 2.16-56.97). Conclusion: Patients with sarcoidosis have a higher risk of both upper and lower GI events compared with subjects without sarcoidosis.